HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mild phenotypic expression of alpha-N-acetylgalactosaminidase deficiency in two adult siblings.

Abstract
Two adult siblings with an alpha-N-acetylgalactosaminidase deficiency are described. The patients' major features are massive lymphoedema and angiokeratoma corporis diffusum. Neurological evaluation performed in one of the patients was considered within normal limits. Blood type is A positive in each case. Ultrastructural examination of skin revealed numerous vacuoles in endothelial cells and pericytes. Fibroblast activity of alpha-N-acetylgalactosaminidase was decreased to 0.6-2% of mean normal value. Chromatography of urinary oligosaccharides showed abnormal bands identical to those excreted by two infantile patients with Schindler disease. The bands were identified as sialyloligosaccharides, and gas chromatography revealed the presence of N-acetylgalactosamine-rich compounds accounting for 30% of the total monosaccharide content of the oligosaccharide fraction. These findings confirm the heterogeneity of alpha-N-acetylgalactosaminidase deficiency and emphasize the need to consider this lysosomal storage disease in the differential diagnosis of patients with angiokeratoma.
AuthorsA Chabás, M J Coll, M Aparicio, E Rodriguez Diaz
JournalJournal of inherited metabolic disease (J Inherit Metab Dis) Vol. 17 Issue 6 Pg. 724-31 ( 1994) ISSN: 0141-8955 [Print] United States
PMID7707696 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Oligosaccharides
  • Hexosaminidases
  • NAGA protein, human
  • alpha-N-Acetylgalactosaminidase
Topics
  • Adult
  • Fabry Disease (enzymology, genetics)
  • Female
  • Hexosaminidases (deficiency, genetics)
  • Humans
  • Lymphedema (enzymology, genetics)
  • Male
  • Oligosaccharides (urine)
  • Phenotype
  • alpha-N-Acetylgalactosaminidase

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: